AAAAAA

   
Results: 1-12 |
Results: 12
DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS
Authors: TWELVES CJ DOBBS NA GILLIES HC JAMES CA RUBENS RD HARPER PG
Citation: Cj. Twelves et al., DOXORUBICIN PHARMACOKINETICS - THE EFFECT OF ABNORMAL LIVER BIOCHEMISTRY TESTS, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 229-234
WHAT IS THE EFFECT OF ADJUSTING EPIRUBICIN DOSES FOR BODY-SURFACE AREA
Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, WHAT IS THE EFFECT OF ADJUSTING EPIRUBICIN DOSES FOR BODY-SURFACE AREA, British Journal of Cancer, 78(5), 1998, pp. 662-666
ANTHRACYCLINE DOSES IN PATIENTS WITH LIVER DYSFUNCTION - DO UK ONCOLOGISTS FOLLOW CURRENT RECOMMENDATIONS
Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, ANTHRACYCLINE DOSES IN PATIENTS WITH LIVER DYSFUNCTION - DO UK ONCOLOGISTS FOLLOW CURRENT RECOMMENDATIONS, British Journal of Cancer, 77(7), 1998, pp. 1145-1148
ARE NEW ANTHRACYCLINE DOSE RECOMMENDATIONS NEEDED FOR PATIENTS WITH LIVER DYSFUNCTION
Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, ARE NEW ANTHRACYCLINE DOSE RECOMMENDATIONS NEEDED FOR PATIENTS WITH LIVER DYSFUNCTION, European journal of cancer, 33, 1997, pp. 692-692
GENDER AFFECTS DOXORUBICIN PHARMACOKINETICS IN PATIENTS WITH NORMAL LIVER BIOCHEMISTRY
Authors: DOBBS NA TWELVES CJ GILLIES H JAMES CA HARPER PG RUBENS RD
Citation: Na. Dobbs et al., GENDER AFFECTS DOXORUBICIN PHARMACOKINETICS IN PATIENTS WITH NORMAL LIVER BIOCHEMISTRY, Cancer chemotherapy and pharmacology, 36(6), 1995, pp. 473-476
COMMENTS ON EPIRUBICIN
Authors: DOBBS NA TWELVES CJ
Citation: Na. Dobbs et Cj. Twelves, COMMENTS ON EPIRUBICIN, Annals of oncology, 5(1), 1994, pp. 98-99
EPIRUBICIN IN HEPATOCELLULAR-CARCINOMA - PHARMACOKINETICS AND CLINICAL ACTIVITY
Authors: DOBBS NA TWELVES CJ RIZZI P WARWICK JD METIVIER EM WILLIAMS R JOHNSON PJ
Citation: Na. Dobbs et al., EPIRUBICIN IN HEPATOCELLULAR-CARCINOMA - PHARMACOKINETICS AND CLINICAL ACTIVITY, Cancer chemotherapy and pharmacology, 34(5), 1994, pp. 405-410
P-31 METABOLISM OF HUMAN BREAST - AN IN-VIVO MAGNETIC-RESONANCE SPECTROSCOPIC STUDY AT 1.5 TESLA
Authors: TWELVES CJ LOWRY M PORTER DA DOBBS NA GRAVES PE SMITH MA RICHARDS MA
Citation: Cj. Twelves et al., P-31 METABOLISM OF HUMAN BREAST - AN IN-VIVO MAGNETIC-RESONANCE SPECTROSCOPIC STUDY AT 1.5 TESLA, British journal of radiology, 67(793), 1994, pp. 36-45
A PHASE-II, MULTICENTER, UK STUDY OF VINORELBINE IN ADVANCED BREAST-CANCER
Authors: TWELVES CJ DOBBS NA CURNOW A COLEMAN RE STEWART AL TYRRELL CJ CANNEY P RUBENS RD
Citation: Cj. Twelves et al., A PHASE-II, MULTICENTER, UK STUDY OF VINORELBINE IN ADVANCED BREAST-CANCER, British Journal of Cancer, 70(5), 1994, pp. 990-993
P-31 METABOLISM OF POSTMENOPAUSAL BREAST-CANCER STUDIED IN-VIVO BY MAGNETIC-RESONANCE SPECTROSCOPY
Authors: TWELVES CJ PORTER DA LOWRY M DOBBS NA GRAVES PE SMITH MA RUBENS RD RICHARDS MA
Citation: Cj. Twelves et al., P-31 METABOLISM OF POSTMENOPAUSAL BREAST-CANCER STUDIED IN-VIVO BY MAGNETIC-RESONANCE SPECTROSCOPY, British Journal of Cancer, 69(6), 1994, pp. 1151-1156
IODODOXORUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II EVALUATION OF CLINICAL ACTIVITY, PHARMACOLOGY AND QUALITY-OF-LIFE
Authors: TWELVES CJ DOBBS NA LAWRENCE MA RAMIREZ AJ SUMMERHAYES M RICHARDS MA TOWLSON KE RUBENS RD
Citation: Cj. Twelves et al., IODODOXORUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II EVALUATION OF CLINICAL ACTIVITY, PHARMACOLOGY AND QUALITY-OF-LIFE, British Journal of Cancer, 69(4), 1994, pp. 726-731
PATIENT ACCEPTABILITY AND PRACTICAL IMPLICATIONS OF PHARMACOKINETIC STUDIES IN PATIENTS WITH ADVANCED CANCER
Authors: DOBBS NA TWELVES CJ RAMIREZ AJ TOWLSON KE GREGORY WM RICHARDS MA
Citation: Na. Dobbs et al., PATIENT ACCEPTABILITY AND PRACTICAL IMPLICATIONS OF PHARMACOKINETIC STUDIES IN PATIENTS WITH ADVANCED CANCER, European journal of cancer, 29A(12), 1993, pp. 1707-1711
Risultati: 1-12 |